Characterization of Fibrinogen as a Key Modulator in Patients with Wilson's Diseases with Functional Proteomic Tools.

MLA

Wang, Pei-Wen, et al. “Characterization of Fibrinogen as a Key Modulator in Patients with Wilson’s Diseases with Functional Proteomic Tools.” International Journal of Molecular Sciences, vol. 20, no. 18, Sept. 2019, p. 4528. EBSCOhost, https://doi.org/10.3390/ijms20184528.

APA

Wang, P.-W., Lin, T.-Y., Hung, Y.-C., Chang, W.-N., Yang, P.-M., Chen, M.-H., Yeh, C.-T., & Pan, T.-L. (2019). Characterization of Fibrinogen as a Key Modulator in Patients with Wilson’s Diseases with Functional Proteomic Tools. International Journal of Molecular Sciences, 20(18), 4528. https://doi.org/10.3390/ijms20184528

Chicago

Wang, Pei-Wen, Tung-Yi Lin, Yu-Chiang Hung, Wen-Neng Chang, Pei-Ming Yang, Mu-Hong Chen, Chau-Ting Yeh, and Tai-Long Pan. 2019. “Characterization of Fibrinogen as a Key Modulator in Patients with Wilson’s Diseases with Functional Proteomic Tools.” International Journal of Molecular Sciences 20 (18): 4528. doi:10.3390/ijms20184528.